327 related articles for article (PubMed ID: 18506688)
1. Breast cancer expression of CD163, a macrophage scavenger receptor, is related to early distant recurrence and reduced patient survival.
Shabo I; Stål O; Olsson H; Doré S; Svanvik J
Int J Cancer; 2008 Aug; 123(4):780-6. PubMed ID: 18506688
[TBL] [Abstract][Full Text] [Related]
2. Expression of the macrophage antigen CD163 in rectal cancer cells is associated with early local recurrence and reduced survival time.
Shabo I; Olsson H; Sun XF; Svanvik J
Int J Cancer; 2009 Oct; 125(8):1826-31. PubMed ID: 19582880
[TBL] [Abstract][Full Text] [Related]
3. Tumor cell expression of CD163 is associated to postoperative radiotherapy and poor prognosis in patients with breast cancer treated with breast-conserving surgery.
Garvin S; Oda H; Arnesson LG; Lindström A; Shabo I
J Cancer Res Clin Oncol; 2018 Jul; 144(7):1253-1263. PubMed ID: 29725763
[TBL] [Abstract][Full Text] [Related]
4. Expression of macrophage antigens by tumor cells.
Shabo I; Svanvik J
Adv Exp Med Biol; 2011; 714():141-50. PubMed ID: 21506012
[TBL] [Abstract][Full Text] [Related]
5. Tumor-associated macrophages are strongly related to vascular invasion, non-luminal subtypes, and interval breast cancer.
Klingen TA; Chen Y; Aas H; Wik E; Akslen LA
Hum Pathol; 2017 Nov; 69():72-80. PubMed ID: 28923419
[TBL] [Abstract][Full Text] [Related]
6. Tumor-promoting macrophages induce the expression of the macrophage-specific receptor CD163 in malignant cells.
Maniecki MB; Etzerodt A; Ulhøi BP; Steiniche T; Borre M; Dyrskjøt L; Orntoft TF; Moestrup SK; Møller HJ
Int J Cancer; 2012 Nov; 131(10):2320-31. PubMed ID: 22362417
[TBL] [Abstract][Full Text] [Related]
7. The presence of tumor associated macrophages in tumor stroma as a prognostic marker for breast cancer patients.
Medrek C; Pontén F; Jirström K; Leandersson K
BMC Cancer; 2012 Jul; 12():306. PubMed ID: 22824040
[TBL] [Abstract][Full Text] [Related]
8. Breast cancer expression of DAP12 is associated with skeletal and liver metastases and poor survival.
Shabo I; Olsson H; Stål O; Svanvik J
Clin Breast Cancer; 2013 Oct; 13(5):371-7. PubMed ID: 23810293
[TBL] [Abstract][Full Text] [Related]
9. Tumor-associated macrophages and crown-like structures in adipose tissue in breast cancer.
Cha YJ; Kim ES; Koo JS
Breast Cancer Res Treat; 2018 Jul; 170(1):15-25. PubMed ID: 29468486
[TBL] [Abstract][Full Text] [Related]
10. The predominance of M2-polarized macrophages in the stroma of low-hypoxic bladder tumors is associated with BCG immunotherapy failure.
Lima L; Oliveira D; Tavares A; Amaro T; Cruz R; Oliveira MJ; Ferreira JA; Santos L
Urol Oncol; 2014 May; 32(4):449-57. PubMed ID: 24252833
[TBL] [Abstract][Full Text] [Related]
11. Macrophage traits in cancer cells are induced by macrophage-cancer cell fusion and cannot be explained by cellular interaction.
Shabo I; Midtbö K; Andersson H; Åkerlund E; Olsson H; Wegman P; Gunnarsson C; Lindström A
BMC Cancer; 2015 Nov; 15():922. PubMed ID: 26585897
[TBL] [Abstract][Full Text] [Related]
12. CD68, CD163, and matrix metalloproteinase 9 (MMP-9) co-localization in breast tumor microenvironment predicts survival differently in ER-positive and -negative cancers.
Pelekanou V; Villarroel-Espindola F; Schalper KA; Pusztai L; Rimm DL
Breast Cancer Res; 2018 Dec; 20(1):154. PubMed ID: 30558648
[TBL] [Abstract][Full Text] [Related]
13. Cancer-associated fibroblasts and CD163-positive macrophages in oral squamous cell carcinoma: their clinicopathological and prognostic significance.
Fujii N; Shomori K; Shiomi T; Nakabayashi M; Takeda C; Ryoke K; Ito H
J Oral Pathol Med; 2012 Jul; 41(6):444-51. PubMed ID: 22296275
[TBL] [Abstract][Full Text] [Related]
14. TGF-beta receptor 2 downregulation in tumour-associated stroma worsens prognosis and high-grade tumours show more tumour-associated macrophages and lower TGF-beta1 expression in colon carcinoma: a retrospective study.
Bacman D; Merkel S; Croner R; Papadopoulos T; Brueckl W; Dimmler A
BMC Cancer; 2007 Aug; 7():156. PubMed ID: 17692120
[TBL] [Abstract][Full Text] [Related]
15. Higher density of stromal M2 macrophages in breast ductal carcinoma in situ predicts recurrence.
Chen XY; Thike AA; Md Nasir ND; Koh VCY; Bay BH; Tan PH
Virchows Arch; 2020 Jun; 476(6):825-833. PubMed ID: 31897820
[TBL] [Abstract][Full Text] [Related]
16. CD68 and CD163 as prognostic factors for Korean patients with Hodgkin lymphoma.
Yoon DH; Koh YW; Kang HJ; Kim S; Park CS; Lee SW; Suh C; Huh J
Eur J Haematol; 2012 Apr; 88(4):292-305. PubMed ID: 22044760
[TBL] [Abstract][Full Text] [Related]
17. AM-3K, an anti-macrophage antibody, recognizes CD163, a molecule associated with an anti-inflammatory macrophage phenotype.
Komohara Y; Hirahara J; Horikawa T; Kawamura K; Kiyota E; Sakashita N; Araki N; Takeya M
J Histochem Cytochem; 2006 Jul; 54(7):763-71. PubMed ID: 16517975
[TBL] [Abstract][Full Text] [Related]
18. Co-expression of parathyroid hormone related protein and TGF-beta in breast cancer predicts poor survival outcome.
Xu C; Wang Z; Cui R; He H; Lin X; Sheng Y; Zhang H
BMC Cancer; 2015 Nov; 15():925. PubMed ID: 26597083
[TBL] [Abstract][Full Text] [Related]
19. Hemoglobin induces monocyte recruitment and CD163-macrophage polarization in abdominal aortic aneurysm.
Rubio-Navarro A; Amaro Villalobos JM; Lindholt JS; Buendía I; Egido J; Blanco-Colio LM; Samaniego R; Meilhac O; Michel JB; Martín-Ventura JL; Moreno JA
Int J Cardiol; 2015 Dec; 201():66-78. PubMed ID: 26296046
[TBL] [Abstract][Full Text] [Related]
20. The Prognostic Impact of CD163-Positive Macrophages in Follicular Lymphoma: A Study from the BC Cancer Agency and the Lymphoma Study Association.
Kridel R; Xerri L; Gelas-Dore B; Tan K; Feugier P; Vawda A; Canioni D; Farinha P; Boussetta S; Moccia AA; Brice P; Chavez EA; Kyle AH; Scott DW; Sanders AD; Fabiani B; Slack GW; Minchinton AI; Haioun C; Connors JM; Sehn LH; Steidl C; Gascoyne RD; Salles G
Clin Cancer Res; 2015 Aug; 21(15):3428-35. PubMed ID: 25869385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
